SEC Form 4 · accession 0001209191-16-142415
IMMUNE DESIGN CORP. · IMDZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
David V Goeddel
10% Owner
COLUMN GROUP L P
10% Owner
COLUMN GROUP II, LP
10% Owner
COLUMN GROUP GP, LP
10% Owner
Column Group II GP, LP
10% Owner
Period of report
Sep 20, 2016
Accepted (ET)
Sep 22, 2016 · 2:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001437786
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Sep 20, 2016 | P | 800,000 | $6.25 | A | 3,961,942 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1the purchase of shares by The Column Group II, LP ("TCG II LP") in the follow-on offering of Common Stock of Immune Design Corp. that closed on September 20, 2016.
- F2Includes shares directly held by TCG II LP and The Column Group, LP ("TCG LP"). The Column Group II GP, LP ("TCG II GP"), as the general partner of TCG II LP, has voting and dispositive power with respect to certain of the shares. The Column Group GP, LP ("TCG GP"), as the general partner of TCG LP, has voting and dispositive power with respect to certain of the shares. The individual managing partners of both TCG II GP and TCG GP are Peter Svennilson and David Goeddel, who may be deemed to have shared voting and dispositive power with respect to the shares. Each individual managing partner disclaims beneficial ownership of the shares, except to the extent of his pecuniary interest in such shares.